References
- Welch RD, Lewis DD. Distraction osteogenesis. Vet Clin North Am Small Anim Pract. 1999;29(5):1187–1205. vii-viii. doi:https://doi.org/10.1016/S0195-5616(99)50109-5.
- Robinson RC, Knapp TR. Distraction osteogenesis in the craniofacial skeleton. Otolaryngol Clin North Am. 2005;38(2):333–359. vii. doi:https://doi.org/10.1016/j.otc.2004.10.012.
- Compton J, Fragomen A, Rozbruch SR. Skeletal repair in distraction osteogenesis: mechanisms and enhancements. JBJS Rev. 2015;3(8):8.doi:https://doi.org/10.2106/JBJS.RVW.N.00107.
- Yang Y, Pan Q, Zou K, Wang H, Zhang X, Yang Z, Lee WYW, Wei B, Gu W, Yang YP, et al. Administration of allogeneic mesenchymal stem cells in lengthening phase accelerates early bone consolidation in rat distraction osteogenesis model. Stem Cell Res Ther. 2020;11(1):129. doi:https://doi.org/10.1186/s13287-020-01635-5.
- Wang Y, Ni M, Tang PF, Li G. Novel application of ha-tcp biomaterials in distraction osteogenesis shortened the lengthening time and promoted bone consolidation. J Orthop Res. 2009;27(4):477–482.doi:https://doi.org/10.1002/jor.20782.
- Suzuki A, Uemura T, Nakamura H. [control of bone remodeling by nervous systemNeural involvement in fracture healing and bone regeneration]. Clin Calcium. 2010;20(12):1820–1827.
- Jones RE, Salhotra A, Robertson KS, Ransom RC, Foster DS, Shah HN, Quarto N, Wan DC, Longaker MT. Skeletal stem cell-schwann cell circuitry in mandibular repair. Cell Rep. 2019;28(11):2757–2766 e2755.doi:https://doi.org/10.1016/j.celrep.2019.08.021.
- Song D, Jiang X, Zhu S, Li W, Khadka A, Hu J. Denervation impairs bone regeneration during distraction osteogenesis in rabbit tibia lengthening. Acta Orthop. 2012;83(4):406–410.doi:https://doi.org/10.3109/17453674.2012.702389.
- Thai J, Kyloh M, Travis L, Spencer NJ, Ivanusic JJ. Identifying spinal afferent (sensory) nerve endings that innervate the marrow cavity and periosteum using anterograde tracing. J Comp Neurol. 2020;528(11):1903–1916.
- Fukuda T, Takeda S, Xu R, Ochi H, Sunamura S, Sato T, Shibata S, Yoshida Y, Gu Z, Kimura A, et al. Sema3a regulates bone-mass accrual through sensory innervations. Nature. 2013;497(7450):490–493. doi:https://doi.org/10.1038/nature12115.
- Wang L, Zhao R, Shi X, Wei T, Halloran BP, Clark DJ, Jacobs CR, Kingery WS. Substance p stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro. Bone. 2009;45(2):309–320.doi:https://doi.org/10.1016/j.bone.2009.04.203.
- Lee NJ, Herzog H. Npy regulation of bone remodelling. Neuropeptides. 2009;43(6):457–463.doi:https://doi.org/10.1016/j.npep.2009.08.006.
- Behar O, Golden JA, Mashimo H, Schoen FJ, Fishman MC. Semaphorin iii is needed for normal patterning and growth of nerves, bones and heart. Nature. 1996;383(6600):525–528.doi:https://doi.org/10.1038/383525a0.
- Polleux F, Morrow T, Ghosh A. Semaphorin 3a is a chemoattractant for cortical apical dendrites. Nature. 2000;404(6778):567–573.doi:https://doi.org/10.1038/35007001.
- Janssen BJ, Robinson RA, Perez-Branguli F, Bell CH, Mitchell KJ, Siebold C, Jones EY. Structural basis of semaphorin-plexin signalling. Nature. 2010;467(7319):1118–1122.doi:https://doi.org/10.1038/nature09468.
- Nogi T, Yasui N, Mihara E, Matsunaga Y, Noda M, Yamashita N, Toyofuku T, Uchiyama S, Goshima Y, Kumanogoh A, et al. Structural basis for semaphorin signalling through the plexin receptor. Nature. 2010;467(7319):1123–1127. doi:https://doi.org/10.1038/nature09473.
- De Winter F, Oudega M, Lankhorst AJ, Hamers FP, Blits B, Ruitenberg MJ, Pasterkamp RJ, Gispen WH, Verhaagen J. Injury-induced class 3 semaphorin expression in the rat spinal cord. Exp Neurol. 2002;175(1):61–75.doi:https://doi.org/10.1006/exnr.2002.7884.
- Hashimoto M, Ino H, Koda M, Murakami M, Yoshinaga K, Yamazaki M, Moriya H. Regulation of semaphorin 3a expression in neurons of the rat spinal cord and cerebral cortex after transection injury. Acta Neuropathol. 2004;107(3):250–256.doi:https://doi.org/10.1007/s00401-003-0805-z.
- Ransom RC, Carter AC, Salhotra A, Leavitt T, Marecic O, Murphy MP, Lopez ML, Wei Y, Marshall CD, Shen EZ, et al. Mechanoresponsive stem cells acquire neural crest fate in jaw regeneration. Nature. 2018;563(7732):514–521. doi:https://doi.org/10.1038/s41586-018-0650-9.
- Li Y, Yang L, He S, Hu J. The effect of semaphorin 3a on fracture healing in osteoporotic rats. J Orthop Sci. 2015;20(6):1114–1121.
- Tse MT. Bone diseases: sema3a strikes a balance in bone homeostasis. Nat Rev Drug Discov. 2012;11(6):442.doi:https://doi.org/10.1038/nrd3759.
- Lotz EM, Berger MB, Boyan BD, Schwartz Z. Regulation of mesenchymal stem cell differentiation on microstructured titanium surfaces by semaphorin 3a. Bone. 2020;134:115260.doi:https://doi.org/10.1016/j.bone.2020.115260.
- Liu L, Wang J, Song X, Zhu Q, Shen S, Zhang W. Semaphorin 3a promotes osteogenic differentiation in human alveolar bone marrow mesenchymal stem cells. Exp Ther Med. 2018;15(4):3489–3494.
- Casazza A, Laoui D, Wenes M, Rizzolio S, Bassani N, Mambretti M, Deschoemaeker S, Van Ginderachter JA, Tamagnone L, Mazzone M. Impeding macrophage entry into hypoxic tumor areas by sema3a/nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity. Cancer Cell. 2013;24(6):695–709.doi:https://doi.org/10.1016/j.ccr.2013.11.007.
- Maione F, Molla F, Meda C, Latini R, Zentilin L, Giacca M, Seano G, Serini G, Bussolino F, Giraudo E. Semaphorin 3a is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models. J Clin Invest. 2009;119(11):3356–3372.
- Huang C, Wang Y, Huang JH, Liu WX. Sema3a drastically suppresses tumor growth in oral cancer xenograft model of mice. BMC Pharmacol Toxicol. 2017;18(1):55.
- Adi SD, Eiza N, Bejar J, Shefer H, Toledano S, Kessler O, Neufeld G, Toubi E, Vadasz Z. Semaphorin 3a is effective in reducing both inflammation and angiogenesis in a mouse model of bronchial asthma. Front Immunol. 2019;22(March);10:550. doi:https://doi.org/10.3389/fimmu.2019.00550.
- Acevedo LM, Barillas S, Weis SM, Gothert JR, Cheresh DA. Semaphorin 3a suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. Blood. 2008;111(5):2674–2680. doi:https://doi.org/10.1182/blood-2007-08-110205
- Aronson J. Temporal and spatial increases in blood flow during distraction osteogenesis. Clin Orthop Relat Res. 1994;(301):124–131.
- Choi IH, Ahn JH, Chung CY, Cho TJ. Vascular proliferation and blood supply during distraction osteogenesis: a scanning electron microscopic observation. J Orthop Res. 2000;18(5):698–705.doi:https://doi.org/10.1002/jor.1100180504.
- Carvalho RS, Einhorn TA, Lehmann W, Edgar C, Al-Yamani A, Apazidis A, Pacicca D, Clemens TL, Gerstenfeld LC. The role of angiogenesis in a murine tibial model of distraction osteogenesis. Bone. 2004;34(5):849–861.doi:https://doi.org/10.1016/j.bone.2003.12.027.
- Pacicca DM, Patel N, Lee C, Salisbury K, Lehmann W, Carvalho R, Gerstenfeld LC, Einhorn TA. Expression of angiogenic factors during distraction osteogenesis. Bone. 2003;33(6):889–898.doi:https://doi.org/10.1016/j.bone.2003.06.002.
- Fang TD, Salim A, Xia W, Nacamuli RP, Guccione S, Song HM, Carano RA, Filvaroff EH, Bednarski MD, Giaccia AJ, et al. Angiogenesis is required for successful bone induction during distraction osteogenesis. Journal of Bone and Mineral Research. 2005;20(7):1114–1124. doi:https://doi.org/10.1359/JBMR.050301.
- Jia YC, Zhu Y, Qiu S, Xu J, Chai YM. Exosomes secreted by endothelial progenitor cells accelerate bone regeneration during distraction osteogenesis by stimulating angiogenesis. Stem Cell Res Ther. 2008;105(2):686–91.
- Wan C, Gilbert SR, Wang Y, Cao X, Shen X, Ramaswamy G, Jacobsen KA, Alaql ZS, Eberhardt AW, Gerstenfeld LC, et al. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci U S A. 2008;105(2):686–691. doi:https://doi.org/10.1073/pnas.0708474105.
- Tay BK, Le AX, Gould SE, Helms JA. Histochemical and molecular analyses of distraction osteogenesis in a mouse model. J Orthop Res. 1998;16(5):636–642.doi:https://doi.org/10.1002/jor.1100160518.
- Seyed Jafari SM, Hunger RE. IHC optical density score: a new practical method for quantitative immunohistochemistry image analysis. Appl Immunohistochem Mol Morphol. 2017;25(1):e12–e13.doi:https://doi.org/10.1097/PAI.0000000000000370.
- Kobayashi T, Kronenberg HM. Overview of skeletal development. Methods Mol Biol. 2014;1130:3–12.
- Carr MJ, Toma JS, Johnston APW, Steadman PE, Yuzwa SA, Mahmud N, Frankland PW, Kaplan DR, Miller FD. Mesenchymal precursor cells in adult nerves contribute to mammalian tissue repair and regeneration. Cell Stem Cell. 2019;24(2):240–256 e249.doi:https://doi.org/10.1016/j.stem.2018.10.024.
- Gharibi B, Abraham AA, Ham J, Evans BA. Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes. J Bone Miner Res. 2011;26(9):2112–2124.doi:https://doi.org/10.1002/jbmr.424.
- Costa MA, Barbosa A, Neto E, Sa-e-Sousa A, Freitas R, Neves JM, Magalhaes-Cardoso T, Ferreirinha F, Correia-de-Sa P. On the role of subtype selective adenosine receptor agonists during proliferation and osteogenic differentiation of human primary bone marrow stromal cells. J Cell Physiol. 2011;226(5):1353–1366.doi:https://doi.org/10.1002/jcp.22458.
- Zhou Y, Gunput RA, Pasterkamp RJ. Semaphorin signaling: progress made and promises ahead. Trends Biochem Sci. 2008;33(4):161–170.doi:https://doi.org/10.1016/j.tibs.2008.01.006.
- Hayashi M, Nakashima T, Taniguchi M, Kodama T, Kumanogoh A, Takayanagi H. Osteoprotection by semaphorin 3a. Nature. 2012;485(7396):69–74.doi:https://doi.org/10.1038/nature11000.
- Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the hif system. Nat Med. 2003;9(6):677–684.doi:https://doi.org/10.1038/nm0603-677.
- Byun JH, Park BW, Kim JR, Lee JH. Expression of vascular endothelial growth factor and its receptors after mandibular distraction osteogenesis. Int J Oral Maxillofac Surg. 2007;36(4):338–344.doi:https://doi.org/10.1016/j.ijom.2006.10.013.
- He JF, Xie ZJ, Zhao H, Ge WL, Hu JA, Li YN, Gu ZY. Immunohistochemical and in-situ hybridization study of hypoxia inducible factor-1alpha and angiopoietin-1 in a rabbit model of mandibular distraction osteogenesis. Int J Oral Maxillofac Surg. 2008;37(6):554–560.doi:https://doi.org/10.1016/j.ijom.2008.01.015.
- Eckardt H, Bundgaard KG, Christensen KS, Lind M, Hansen ES, Hvid I. Effects of locally applied vascular endothelial growth factor (VEGF) and VEGF-inhibitor to the rabbit tibia during distraction osteogenesis. J Orthop Res. 2003;21(2):335–340.doi:https://doi.org/10.1016/S0736-0266(02)00159-6.
- Park BH, Yoon SJ, Jang KY, Kim MR, Lee HS, Kim KB, Park H, Lee SY, Park HS, Lim ST, et al. Comp-angiopoietin-1 accelerates bone formation during distraction osteogenesis. Bone 2010;46:1442–1448.
- Jing D, Zhang S, Luo W, Gao X, Men Y, Ma C, Liu X, Yi Y, Bugde A, Zhou BO, et al. Tissue clearing of both hard and soft tissue organs with the pegasos method. Cell Res 2018;28:803–818.